Dechra Pharmaceuticals has now released its interim results for the year ending 2016. Revenues increased when compared to the first half of last year with a £9.1M growth in North American revenues, aided by a strong US dollar, and a … Continue reading
Gemfields has now released its interim results for the year ending 2016. Revenues declined by $9.4M when compared to the first half of last year. We also see an increase in costs as a $1.9M decline in depreciation & amortisation, … Continue reading
XP Power has now released its final results for the year ended 2015. Revenues increased when compared to last year as a £500K decline in industrial revenue was more than offset by a £5.8M growth in technology revenue and a … Continue reading
Avingtrans has now released its interim results for the year ending 2016. Revenues declined when compared to the first half of last year as a £632K growth in aerospace revenue was more than offset by a £1.9M decrease in energy … Continue reading
Avingtrans is engaged in the provision of highly engineered components, systems and services and has two main divisions. In the civil aerospace market the group produces pipes for a number of aero engine suppliers into the civil airliner market and … Continue reading
Spectris has now released its final results for the year ended 2015. Revenues increased when compared to last year, although on a like for like basis they were flat as a £15.6M growth in Materials Analysis revenue and an £8.4M … Continue reading
Amino Technologies has now released its final results for the year ended 2015. Revenues increased when compared to last year as a result of the acquisitions as a £3.5M crash in Serbian revenue and a £266K decline in Chile revenue … Continue reading
Brooks MacDonald offers a range of investment management services and related professional advice to private high net worth individuals, charities and trusts. They also provide financial planning as well as offshore fund management and admin services and acts as fund … Continue reading
Galliford Try is a UK housebuilding and construction group. The housebuilding division comprises Linden Homes which develops both private and affordable homes for sale, and Galliford Try Partnerships, a specialist affordable housing business. In construction the group is a major … Continue reading
There will be some changes to the business split going forward as ViiV Healthcare will be merged into the Global Pharmaceuticals segment, which is a bit of a shame in my view. The results this year include ten months of … Continue reading